Skip to main content

Security report for msd.cz

MSD Czech Republic · Healthcare · Czech Republic

Medium risk. 3 critical or high findings in GDPR outside view and SSL/TLS.

Security score

75/100

Risk levelMedium

0–100, higher is better. How it is calculated

MSD Czech Republic is a leading biopharmaceutical company with a strong focus on research, development, and innovation in healthcare. The company has a well-established market position supported by over 130 years of history and is part of the global Merck & Co., Inc. group. Their website reflects a professional corporate presence targeting healthcare professionals, patients, and job seekers, offering detailed information about their services, research, and career opportunities. Technically, the site is built on WordPress with modern SEO and accessibility practices, supported by Google Tag Manager and OneTrust for privacy compliance. Security posture is strong with HTTPS and cookie consent mechanisms, though some security headers could be improved. Overall, the site is trustworthy, compliant with GDPR, and provides a positive user experience.

Scanned

NIS2 and GDPR posture

GDPR outside view
73/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1
    • High

      Weak SSL Key Length

      SSL certificate uses 256-bit key, which is considered weak

      What to do: Use at least 2048-bit RSA or 256-bit ECC key

      • CWE-326
      • OWASP A04:2025
      • Mozilla TLS: Mozilla Server Side TLS 6.0 intermediate: rsa_key_size 2048

Need hands-on remediation? Email guard@offseq.com

Keep watching msd.cz

This scan found 19 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
42
Security headers
80
Email security
70
DNS health
85
Network security
100
GDPR outside view
73
Average
75

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

MSD Czech Republic operates in the healthcare sector, focusing on innovative pharmaceutical products and clinical research. Their business model revolves around R&D, manufacturing, and distribution of medicines, with a strong emphasis on digital transformation and IT services within the company. The company targets healthcare professionals, patients, and potential employees, maintaining a robust partnership ecosystem including specialized portals for doctors and animal health. Their market position is strong as a leading pharmaceutical entity in the Czech Republic, supported by global parentage. Growth indicators include certifications like Top Employer 2025 and active engagement in digital healthcare solutions.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, cookie consent, and external link warnings to protect users from third-party risks. However, explicit security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options are not visibly implemented and should be added to enhance protection against common web attacks. No exposed sensitive data or vulnerable libraries were detected. Incident response and security policy information are not publicly available on the site, representing an area for improvement. Overall, the security measures align with industry standards but could benefit from additional hardening and transparency.

Recommendations

  1. Implement comprehensive security headers including CSP, X-Frame-Options, and X-Content-Type-Options to mitigate common web vulnerabilities.
  2. Publish a dedicated security policy and provide clear incident response contact channels to improve transparency and trust.
  3. Regularly audit and update third-party scripts and plugins to avoid vulnerabilities.
  4. Enhance data protection officer visibility and GDPR compliance documentation on the website.
  5. Consider adding a security.txt file to facilitate responsible vulnerability disclosure.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
MSD Czech Republic
Description
MSD is a leading global biopharmaceutical company focused on research and development of medicines against serious diseases for over 130 years. They provide innovative treatments, support prevention and healthy lifestyles, and are active in clinical research.
Key services
Innovative medicines, Clinical research, Prevention and health promotion, IT and digital healthcare solutions, Financial services within MSD
Content quality
excellent
Branding
consistent

Technology

Stack
WordPress, Yoast SEO plugin, Tiny Slider, Google Tag Manager, OneTrust Cookie Consent
Frameworks
WordPress CMS
Platforms
Web
Performance
moderate
Mobile
good
Accessibility
good
SEO
excellent

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Cookie consent mechanism implemented
  • External link warning modal for third-party links
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Google Analytics (via Google Tag Manager)
Marketing tools
OneTrust Cookie Consent
Transparency
good

Site quality

Design
excellent
User experience
excellent
Content relevance
excellent
Navigation
excellent
Professionalism
excellent
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured.
  2. Strong focus on healthcare and pharmaceutical industry.
  3. Comprehensive privacy and cookie policies with consent mechanisms.
  4. Active social media presence with verified accounts.
  5. No signs of malicious or suspicious content.
  6. Good SEO and accessibility practices implemented.
  7. No direct contact emails or phone numbers found on main page; contact via form only.
  8. External links to trusted domains only.
  9. Use of modern web technologies and compliance tools.
Technical notes

Notes

The website is built on a WordPress CMS platform using modern plugins such as Yoast SEO for search optimization and Tiny Slider for interactive content. Google Tag Manager is used for analytics and marketing tracking, integrated with OneTrust for cookie consent management. The site is mobile-optimized with responsive design and good accessibility features. Performance is moderate, with room for optimization in loading speed. The technical infrastructure is stable and professional, but could benefit from enhanced security headers and performance tuning to reduce technical debt and improve user experience.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Earlier scans of this domain

  1. 75/100Medium28 findingsView report
Reviews of this site

Share your experience with msd.cz. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review msd.cz.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.